Investigating how IL-17A contributes to psoriatic arthritis

Cellular and Molecular Mechanisms of IL-17A in the Pathogenesis of Psoriatic Arthritis

NIH-funded research Beth Israel Deaconess Medical Center · NIH-11164302

This study is looking at how a protein called IL-17A contributes to psoriatic arthritis, which causes joint pain and inflammation, using a special animal model to find new ways to help people with this condition feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11164302 on NIH RePORTER

What this research studies

This research focuses on understanding the role of IL-17A in the development of psoriatic arthritis (PsA), a condition that causes painful inflammation in the joints. The researchers have created a novel animal model that mimics the symptoms of PsA, allowing them to study the cellular and molecular mechanisms involved in the disease. By examining how IL-17A signaling affects joint and skin inflammation, the team aims to identify new therapeutic targets that could lead to more effective treatments for patients suffering from PsA.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with psoriatic arthritis who may benefit from new treatment options.

Not a fit: Patients with other forms of arthritis or those not diagnosed with psoriatic arthritis may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of targeted therapies that improve treatment outcomes for patients with psoriatic arthritis.

How similar studies have performed: Previous research has shown promising results in targeting IL-17A for psoriasis treatment, but this approach for psoriatic arthritis is still being explored and is considered novel.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.